Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos
Executive Summary
Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.
You may also be interested in...
Pipeline Watch: Phase III Readouts In Ovarian Cancer, Depression And Epidermolysis Bullosa Among Others
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Moderna Shone As COVID-19 Breakthroughs Were Rewarded At The 17th Annual Scrip Awards
The pharma, biotech and allied industries came back together in London on 2 December to celebrate a year of exceptional achievement at the 17th Annual Scrip Awards, hosted by the journalist and broadcaster Amol Rajan.
Executives On The Move: Changes At Acceleron, Faron Pharmaceuticals And More
C-suite changes at Relief Therapeutics and promotions at Black Diamond Therapeutics are among recent executive changes in the industry. Meanwhile, new directors were appointed at Adagio Therapeutics, OKYO Pharma and Tenaya Therapeutics, among others.